Annual Total Long Term Liabilities
$116.67 M
+$67.38 M+136.70%
December 31, 2023
Summary
- As of February 7, 2025, MDGL annual total long term liabilities is $116.67 million, with the most recent change of +$67.38 million (+136.70%) on December 31, 2023.
- During the last 3 years, MDGL annual total long term liabilities has risen by +$116.20 million (+24828.63%).
- MDGL annual total long term liabilities is now -4.93% below its all-time high of $122.72 million, reached on December 31, 2008.
Performance
MDGL Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$118.26 M
+$756.00 K+0.64%
September 30, 2024
Summary
- As of February 7, 2025, MDGL quarterly total long term liabilities is $118.26 million, with the most recent change of +$756.00 thousand (+0.64%) on September 30, 2024.
- Over the past year, MDGL quarterly long term liabilities has increased by +$756.00 thousand (+0.64%).
- MDGL quarterly long term liabilities is now -8.98% below its all-time high of $129.93 million, reached on March 31, 2009.
Performance
MDGL Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
MDGL Long Term Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +136.7% | +0.6% |
3 y3 years | +10000.0% | +0.6% |
5 y5 years | +100.0% | +0.6% |
MDGL Long Term Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | >+9999.0% | at high | >+9999.0% |
5 y | 5-year | at high | >+9999.0% | at high | >+9999.0% |
alltime | all time | -4.9% | -100.0% | -9.0% | -100.0% |
Madrigal Pharmaceuticals Long Term Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $118.26 M(+0.6%) |
Jun 2024 | - | $117.51 M(+0.3%) |
Mar 2024 | - | $117.18 M(+0.4%) |
Dec 2023 | $116.67 M(+136.7%) | $116.67 M(+0.5%) |
Sep 2023 | - | $116.05 M(+16.9%) |
Jun 2023 | - | $99.25 M(+18.2%) |
Mar 2023 | - | $83.97 M(+70.4%) |
Dec 2022 | $49.29 M(>+9900.0%) | $49.29 M(+0.5%) |
Sep 2022 | - | $49.05 M(+0.4%) |
Jun 2022 | - | $48.85 M(>+9900.0%) |
Mar 2022 | - | $283.00 K(-26.9%) |
Dec 2021 | $387.00 K(-17.3%) | $387.00 K(-21.2%) |
Sep 2021 | - | $491.00 K(-17.3%) |
Jun 2021 | - | $594.00 K(+53.5%) |
Mar 2021 | - | $387.00 K(-17.3%) |
Dec 2020 | $468.00 K(+29.6%) | $468.00 K(-14.6%) |
Sep 2020 | - | $548.00 K(+178.2%) |
Jun 2020 | - | $197.00 K(-29.4%) |
Mar 2020 | - | $279.00 K(-22.7%) |
Dec 2019 | $361.00 K(>+9900.0%) | $361.00 K(-18.1%) |
Sep 2019 | - | $441.00 K(-15.2%) |
Jun 2019 | - | $520.00 K(-13.0%) |
Mar 2019 | - | $598.00 K(>+9900.0%) |
Dec 2018 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2018 | - | $0.00(0.0%) |
Jun 2018 | - | $0.00(0.0%) |
Mar 2018 | - | $0.00(0.0%) |
Dec 2017 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2017 | - | $0.00(0.0%) |
Jun 2017 | - | $0.00(0.0%) |
Mar 2017 | - | $0.00(0.0%) |
Dec 2016 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2016 | - | $0.00(0.0%) |
Jun 2016 | - | $0.00(0.0%) |
Mar 2016 | - | $0.00(0.0%) |
Dec 2015 | $0.00 | $0.00(-100.0%) |
Sep 2015 | - | $11.00 K(-65.6%) |
Jun 2015 | - | $32.00 K(-98.6%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2015 | - | $2.33 M(-49.8%) |
Dec 2014 | $4.65 M(-66.6%) | $4.65 M(-33.3%) |
Sep 2014 | - | $6.97 M(-24.9%) |
Jun 2014 | - | $9.28 M(-19.9%) |
Mar 2014 | - | $11.60 M(-16.6%) |
Dec 2013 | $13.90 M(+211.4%) | $13.90 M(-13.7%) |
Sep 2013 | - | $16.12 M(-12.5%) |
Jun 2013 | - | $18.42 M(-10.4%) |
Mar 2013 | - | $20.55 M(+360.1%) |
Dec 2012 | $4.46 M(-64.0%) | $4.46 M(-30.9%) |
Sep 2012 | - | $6.46 M(-23.5%) |
Jun 2012 | - | $8.45 M(-19.0%) |
Mar 2012 | - | $10.43 M(-15.9%) |
Dec 2011 | $12.40 M(-10.5%) | $12.40 M(+1.9%) |
Sep 2011 | - | $12.17 M(-12.0%) |
Jun 2011 | - | $13.84 M(+10.6%) |
Mar 2011 | - | $12.51 M(-9.7%) |
Dec 2010 | $13.85 M(+84.0%) | $13.85 M(-16.9%) |
Sep 2010 | - | $16.67 M(+250.0%) |
Jun 2010 | - | $4.76 M(-22.1%) |
Mar 2010 | - | $6.12 M(-18.8%) |
Dec 2009 | $7.53 M(-93.9%) | $7.53 M(-16.0%) |
Sep 2009 | - | $8.97 M(-13.9%) |
Jun 2009 | - | $10.41 M(-92.0%) |
Mar 2009 | - | $129.93 M(+5.9%) |
Dec 2008 | $122.72 M(+59.4%) | $122.72 M(+25.1%) |
Sep 2008 | - | $98.14 M(+28.2%) |
Jun 2008 | - | $76.55 M(+1.5%) |
Mar 2008 | - | $75.39 M(-2.1%) |
Dec 2007 | $76.98 M(+71.1%) | $76.98 M(+2368.1%) |
Sep 2007 | - | $3.12 M(-4.6%) |
Jun 2007 | - | $3.27 M(-3.0%) |
Mar 2007 | - | $3.37 M(-92.5%) |
Dec 2006 | $44.99 M(+956.4%) | $44.99 M(+1.2%) |
Sep 2006 | - | $44.44 M(+943.3%) |
Dec 2005 | $4.26 M(+258.5%) | $4.26 M(+170.9%) |
Mar 2005 | - | $1.57 M |
Dec 2004 | $1.19 M(>+9900.0%) | - |
Dec 2001 | $0.00 | - |
FAQ
- What is Madrigal Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals annual total long term liabilities year-on-year change?
- What is Madrigal Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Madrigal Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of MDGL is $116.67 M
What is the all time high annual total long term liabilities for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high annual total long term liabilities is $122.72 M
What is Madrigal Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, MDGL annual total long term liabilities has changed by +$67.38 M (+136.70%)
What is Madrigal Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of MDGL is $118.26 M
What is the all time high quarterly long term liabilities for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high quarterly total long term liabilities is $129.93 M
What is Madrigal Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, MDGL quarterly total long term liabilities has changed by +$756.00 K (+0.64%)